Multi-Client Studies
Sometimes the market evolves so quickly, and with such complexity, that companies struggle to stay abreast of the changes. The Zitter Group’s syndicated, multi-client market research products were developed to help companies understand the environment as it evolves.
Each research product combines the same methodological rigor and rich market expertise that inform our primary market research projects. We use large samples of 100 or more managed care decision-makers, carefully constructed to ensure reliable, representative results. We also work closely with our clients to identify and frame key issues for deeper study and analysis. As a result, our syndicated research doesn’t have that off-the-shelf feel – it reflects the top concerns of the top companies in the industry.
We believe that by working with our clients to target the key issues, we ensure that the results produce helpful insights into market dynamics.
The Managed Care Biologics and Injectables Index
The Managed Care Biologics and Injectables Index (MCBII) is the largest and longest running quantitative assessment of managed care market dynamics affecting biologic and injectable therapies. This semi-annual, multi-client study surveys approximately 100 top payer decision makers to explore a wide range of payer management issues including physician reimbursement, prior authorization, patient cost-sharing, specialty pharmacy, biosimilars, cross-benefit management, innovative contracting, co-pay assistance, and category-specific market dynamics.
The Managed Care Benefit Design Index: Emerging Trends in Access
The Managed Care Benefit Design Index (MCBDI) is the only study focused on the drivers of benefit design and its impact on the management and use of biopharmaceutical therapies. This semi-annual, multi-client study surveys approximately 100 top payer decision makers and 100 self-insured employers and employee benefits consultants to explore the trends influencing the creation of benefit design policies.
The Managed Care Oncology Index
The Managed Care Oncology Index (MCOI) is a semi-annual, multi-client study surveying approximately 100 payers, 100 oncologists, and 100 oncology practice managers. Started in 2006, the survey explores a wide range of payer oncology management issues, including physician reimbursement, prior authorization, patient cost-sharing, specialty pharmacy, site of care dynamics, practice economics, and clinical guidelines.